NCT03308669View on ClinicalTrials.gov

A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

December 2, 2017

Study Completion Date

December 2, 2017

Conditions
Healthy
Interventions
DRUG

Lasmiditan

Administered orally

DRUG

Placebo

Administered orally

DRUG

Topiramate

Administered orally

Trial Locations (1)

53704

Covance Madison CRU, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03308669 - A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate | Biotech Hunter | Biotech Hunter